InvestorsHub Logo
Followers 45
Posts 6228
Boards Moderated 0
Alias Born 06/17/2009

Re: Pineapple1 post# 117624

Monday, 08/28/2017 8:41:18 PM

Monday, August 28, 2017 8:41:18 PM

Post# of 461266
Folks, I don't believe Dr. M is looking to market 2-73 in the $1,000+ a month range. As we all point out, the research and development costs of 2-73 is nowhere near what the troglodytes have spent in their antiqued-thinking attempt to stop AD. Anavex's recovery of R&D is less than 1% of that groups' costs.

IMO, Dr. M will structure the pricing such that Anavex will receive between $600-900/year/patient on AD, probably less for other diseases/illnesses.

He has compassion, I believe, for those suffering and is not interested in gouging patients and their families.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News